RE:RE:RE:RE:Where We Are NowGood point Storm23.
Don has obviously been very busy getting the financing, hiring a Zenith CEO, etc. By hiring the new Zenith CEO it achieves a few important things;
- It brings a high degree of credibility to the Zenith brand. She would not have taken the job unless she believes in the potential.
- It brings in a person with excellent scientific depth and knowledge as well as a large network within the BP industry.
- In brings in a person with significant business experience and importantly a track record of achieving drug approvals with the FDA.
- A person capable of managing the IPO structures and roll outs.
- It frees up Don's time to focus all of his attention on RVX in terms of continuing to make connections with BP in order to set the groundwork for a possible sale.
- Don should be able to dedicate some time to shareholder value.
- AND, hahaha, it frees up Don's time to hire a competent communications expert so that the kind of failure that occurred on the communications of the diabetes trial results never happens again.
Let's hope the action and pace increases. I would assume that RVX has been working on the ph2c trial design for at least the past 8 months and it that it should fall into place immediately at or before the financing vote (given that the financing will definitely be approved).
There's too many good things happening. I guess it will all depend on the trial. GLTA.
Cheers
Toinv